A multinational Phase 3 registrational trial of Vibegron.
Phase of Trial: Phase III
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Vibegron (Primary)
- Indications Overactive bladder
- Focus Registrational; Therapeutic Use
- Sponsors Urovant Sciences
- 19 Jun 2017 New trial record
- 06 Jun 2017 According to a Roivant Sciences media release, company plans to initiate this trial in 2017.